Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: Implications in pulmonary arterial hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Lee, Jason E ^a   Patel, Kirit ^a   Almodóvar, Sharilyn ^b   Tuder, Rubin M ^b   Flores, Sonia C ^b   Sehgal, Pravin B ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

soluble n ethylmaleimide sensitive factor acceptor protein; Endothelial nitric oxide synthase mislocalization; Giantin; GM130; Golgi fragmentation; Nitric oxide scavenging; P115; Subcellular three dimensional immunoimaging; Vti1a

Indexed keywords

DYNAMIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GIANTIN PROTEIN; GM130 PROTEIN; N ETHYLMALEIMIDE SENSITIVE FACTOR; NEF PROTEIN; NITRIC OXIDE; P115 PROTEIN; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; SNARE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BIOAVAILABILITY; CELL FUNCTION; CELL SIZE; CELL SURFACE; CELL TYPE; COW; DEPLETION; ENDOSOME; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; LUNG ENDOTHELIUM; MACACA; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN TRANSPORT; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; QUANTITATIVE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; SMOOTH MUSCLE FIBER; THREE DIMENSIONAL IMAGING; TISSUE SECTION;

ANIMALS; CATTLE; CELL LINE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; GOLGI APPARATUS; HUMANS; HYPERTENSION, PULMONARY; MACACA; MICROTUBULES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PULMONARY ARTERY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

EID: 79955068228     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00767.2010     Document Type: Article

References (79)

1. Annunziata P. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into mechanisms. J Neurol 250: 901-906, 2003.
2. Barchowsky A, Soucy NV, O'Hara KA, Hwa J, Noreault TL, Andrew AS. A novel pathway for nickel-induced interleukin-8 expression. J Biol Chem 277: 24225-24231, 2002.
3. Beske O, Reichert M, Taylor MP, Kirkegaard K, Andino R. Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci 120: 3207-3218, 2007.
4. Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM. Inhaled NO as a therapeutic agent. Cardiovasc Res 75: 339-348, 2007.
5. Bonifacino JS, Glick BS. The mechanism of vesicle budding and fusion. Cell 116: 153-166. 2004.
6. Cajal SR. Algunas variaciones fisiológicas y patológicas del aparato reticular de Golgi. Trab Lab Inv Biol Madrid 12: 127-227, 1914.
7. Caliguiri LA, Tamm I. Membrane structures associated with translation and transcription of poliovirus RNA. Science 166: 885-886, 1969.
8. Caliguiri LA, Tamm I. The role of cytoplasmic membranes in poliovirus biosynthesis. Virology 42: 100-111, 1970.
9. Duffy P, Wang X, Lin PH, Yao Q, Chen C. HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res 156: 257-264, 2009.
10. Edgell CJS, Haizlip JE, Bagnell R, Packenham JP, Harrison P, Wilbourn B, Madden VJ. Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol 26: 1167-1172, 1990.
11. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737, 1983.
12. Fagan KA, Fouty BW, Tyler RC, Morris KG Jr, Hepler LK, Sato K, LeCras TD, Abman SH, Weinberger HD, Huang PL, McMurtry IF, Rodman DM. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 103: 291-299, 1999.
13. Farquhar MG, Palade GE. The Golgi apparatus (complex)-(1954- 1981)-from artifact to center stage. J Cell Biol 91: 77s-103s, 1981.
14. Fernández-Hernando C, Fukata M, Bernatchez PN, Fukata Y, Lin MI, Bredt DS, Sessa WC. Identification of Golgi-localized acyl trans-ferases that palmitoylate and regulate endothelial nitric oxide synthase. J Cell Biol 174: 369-377, 2006.
15. Frank DB, Lowery J, Anderson L, Brink M, Reese J, de Caestecker M. Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 294: L98-L109, 2008.
16. Freundt EC, Goldsmith CS, Welsh S, Cheng A, Yount B, Liu W, Frieman MB, Bucholcz UJ, Screaton GR, Lippincott-Schwartz J, Zaki SR, Xu XN, Baric RS, Subbrao K, Lenardo MJ. The open reading frame 3a protein of severe acute respiratory syndrome-associated corona-virus promotes membrane rearrangement and cell death. J Virol 84: 1097-1109, 2010.
17. German Z, Chambliss KL, Pace MC, Arnet UA, Lowenstein CJ, Shaul PW. Molecular basis of cell-specific endothelial nitric-oxide syn-thase expression in airway epithelium. J Biol Chem 275: 8183-8189, 2000.
18. Giad A, Saleh D. Reduced expression of endothelial nitric oxide synthase in lungs of patients with pulmonary hypertension. N Engl J Med 333: 214-221, 1995.
19. Gladwin MT, Schecter AN, Shelhamer JH, Ognibene FP. The acute chest syndrome in sickle cell disease: possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 159: 1368-1376, 1999.
20. Gladwin MT, Schecter AN, Shelhamer JH, Pannell LK, Conway DA, Hrinczenko BW, Nichols JS, Pease-Fye ME, Noguchi CT, Rodgers GP, Ognibene FP. Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest 104: 937-945, 1999.
21. Golgi C. Sur la structure des cellules nerveuses. Arch Ital Biol 30: 60-71, 1898.
22. Graesmans H, van's Gravesande KS, Buscher R, Knauer N, Silver-man ES, Palmer LJ, Drazen JM, Ratjen F. Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med 167: 390-394, 2003.
23. Hiyoshi M, Suzu S, Yoshidomi Y, Hassan R, Harada H, Sakashita N, Akan H, Motoyoshi K, Okada S. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Blood 111: 243-250, 2008.
24. Iwakiri Y, Satoh A, Chatterjee S, Toomre DK, Chalouni CM, Fulton D, Groszmann RJ, Shah VH, Sessa WC. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci USA 103: 19777-19782, 2006.
25. Kang-Decker N, Cao S, Chatterjee S, Yao J, Egan LJ, Semela D, Mukhopadhyay D, Shah V. Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. J Cell Sci 120: 492-501, 2007.
26. Krasteva G, Pfeil U, Filip AM, Lips KS, Kummer W, Konig P. Caveolin-3 and eNOS colocalize and interact in ciliated airway epithelial cells in the rat. Int J Biochem Cell Biol 39: 615-625, 2007.
27. Lappin PB, Ross KL, King LE, Fraker PJ, Roth RA. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo. Toxicol Appl Pharmacol 150: 37-48, 1998.
28. Lee J, Reich R, Xu F, Sehgal PB. Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging. Am J Physiol Lung Cell Mol Physiol 297: L715-L728, 2009.
29. Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JX, Jamieson SW, Thistlewaite PA. Notch 3 signaling promotes the development of pulmonary hypertension. Nat Med 15: 1289-1297, 2009.
30. Machado RF, Gladwin MT. Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease-the global perspective. Chest 137: 30S-38S, 2010.
31. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839-850, 2006.
32. Mallard F, Tang BL, Galli T, Tenza D, Saint-Pol A, Yue X, Antomny C, Hong W, Goud B, Johaness L. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol 156: 653-664, 2002.
33. Mandegar M, Thistlewaite PA, Yuan JX. Molecular biology of primary pulmonary hypertension. Cardiol Clin 22: 417-429, 2004.
34. Mandell CP, Reyes RA, Cho K, Sawai ET, Fang AL, Schmidt KA, Luciw PA. SIV/HIV Nef recombinant virus (SHIV nef) produces simian AIDS in rhesus macaques. Virology 265: 235-251, 1999.
35. Marecki JC, Cool CD, Parr JE, Beckley VE, Luciw PA, Tarantal AF, Carville A, Shannon RP, Cota-Gomez A, Tuder RM, Voelkel NF, Flores SF. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med 174: 437-445, 2006.
36. Martin-Acebes MA, González-Magaldi M, Rosas MF, Borrego B, Brocchi E, Armas-Portela R, Sobrino F. Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and vesicular stomatitis virus. Virology 374: 432-443, 2008.
37. Mason CAE, Chang P, Fallery C, Rabinovitch M. Nitric oxide mediates LC-3-dependent regulation of fibronectin in ductus arteriosus intimal cushion formation. FASEB J 13: 1423-1434, 1999.
38. Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB. Disruption of endothelial-cell caveolin-1a/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110: 1499-1506, 2004.
39. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C, Hara MR, Quick RA, Cao W, O'Rourke B, Lowenstein JM, Pesner J, Wagner DD, Lowenstein CJ. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115: 139-150, 2003.
40. Mattocks AR, Jukes R, Brown J. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 27: 561-567, 1989.
41. 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am J Pathol 106: 84-94, 1982.
42. Morré DJ, Mollenhauer HH. The Golgi Apparatus-the First 100 Years. New York: Springer, 2009.
43. Mukhopadhyay S, Lee J, Sehgal PB. Depletion of the ATPase NSF from Golgi membranes with hypo-S-nitrosylation of vasorelevant proteins in endothelial cells exposed to monocrotaline pyrrole. Am J Physiol Heart Circ Physiol 295: H1943-H1955, 2008.
44. Mukhopadhyay S, Sehgal PB. Discordant regulatory changes in monocrotaline-induced megalocytosis of lung arterial endothelial and alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L1216-L1226, 2006.
45. Mukhopadhyay S, Shah M, Patel K, Sehgal PB. Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response. Toxicol Appl Pharmacol 211: 209-220, 2006.
46. Mukhopadhyay S, Xu F, Sehgal PB. Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia and senescence: subcellular eNOS localization and live-cell caveolar and cytoplasmic NO imaging studies. Am J Physiol Heart Circ Physiol 293: H77-H85, 2007.
47. Nakamura N. Emerging new roles of GM130, a cis-Golgi matrix protein, in higher order cell functions. J Pharmacol Sci 112: 255-264, 2010.
48. Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz KH, Eisenbrand G, Jove R. Indirubin derivatives inhibit stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA 102: 5998-6003, 2005.
49. Orth JD, Krueger EW, Cao H, McNiven MA. The large GTPase dynamin regulates actin comet formation and movement in living cells. Proc Natl Acad Sci USA 99: 167-172, 2002.
50. Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybernetics 9: 62-66, 1979.
51. Palmer LA, Doctor A, Chhabra P, Sheram ML, Laubach VE, Kar-linsky MZ, Forbes MS, Macdonald T, Gaston B. S-nitrosothiols signal hypoxia-mimetic vascular pathology. J Clin Invest 117: 2592-2601, 2007.
52. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robina C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O. Modifier effect of ENOS in auto-somal dominant polycystic disease. Hum Mol Genet 11: 229-241, 2002.
53. Poland SD, Rice GP, Dekabian GA. HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J Acquir Immune Defic Syndr Hum Retrovirol 8: 437-445, 1995.
54. Puthenveedu MA, Bachert C, Puri S, Lanni F, Linstedt AD. GM130 and GRASP65-dependent lateral cisternal fusion allows uniform Golgi-enzyme distribution. Nat Cell Biol 8: 238-248, 2006.
55. Qian J, Zhang Q, Church JE, Stepp DW, Rudic RD, Fulton DJ. Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation. Am J Physiol Heart Circ Physiol 298: H112-H118, 2010.
56. Quiner CA, Jackson WT. Fragmentation of the Golgi apparatus provides replication membranes for human rhinovirus 1A. Virology 407: 185-195, 2010.
57. Rabinovitch M. Molecular pathogenesis of pulmonary hypertension. J Clin Invest 118: 2372-2379, 2008.
58. Resta TC, Gonzales RJ, Dail WG, Sanders TC, Walker BR. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am J Physiol Heart Circ Physiol 272: H806-H813, 1997.
59. Rudrakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11: 1517-1525, 2002.
60. Salanueva IJ, Novoa RR, Cabezas P, López-Iglesias C, Carrascosa JL, Elliott RM, Risco C. Polymorphism and structural maturation of buny-amvera virus in Golgi and post-Golgi compartments. J Virol 77: 1368-1381, 2003.
61. Seemann J, Jokitalo EJ, Warren G. The role of the tethering proteins p115 and GM130 in transport through the Golgi apparatus in vivo. Mol Biol Cell 11: 635-645, 2000.
62. Sehgal PB, Lee JE. Protein trafficking dysfunctions: role in pathogenesis of PAH. Pulm Circ. In press.
63. Sehgal PB, Mukhopadhyay S. Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol 293: H77-H85, 2007.
64. Sehgal PB, Mukhopadhyay S. Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension. Am J Respir Cell Mol Biol 37: 31-37, 2007.
65. Sehgal PB, Mukhopadhyay S, Patel K, Xu F, Almodóvar S, Tuder RM, Flores SC. Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol 297: L729-L737, 2009.
66. Sehgal PB, Mukhopadhyay S, Xu F, Patel K, Shah M. Dysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 292: L1526-L1542, 2007.
67. Shah M, Patel K, Sehgal PB. Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism. Am J Physiol Cell Physiol 288: C850-C862, 2005.
68. Shajahan AN, Timblin BK, Sandoval R, Tiruppathi C, Malik AB, Minshall RD. Role of src-induced dynamin-2 phosphorylation in cave-olae-mediated endocytosis in endothelial cells. J Biol Chem 279: 20392-20400, 2004.
69. Shaul PW, Afshar S, Gibson LL, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283: L1192-L1199, 2002.
70. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 297: L1013-L1032, 2009.
71. Tinkle BT, Ngo L, Luciw PA, Maciag T, Jay G. Human immunodeficiency virus-associated vasculopathy in transgenic mice. J Virol 71: 4809-4814, 1997.
72. Tuder RM, Marecki JC, Richter A, Fijlkowska I, Flores S. Pathology of pulmonary hypertension. Clin Chest Med 28: 23-42, 2007.
73. Tyler RC, Muramatsu M, Abman SH, Stelzner TJ, Rodman DM, Bloch KD, McMurtry IF. Variable expression of endothelial NO syn-thase in three forms of rat pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 276: L297-L303, 1999.
74. Weller SG, Capitani M, Cao H, Micaroni M, Luini A, Sallese M, McNiven MA. Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2. Proc Natl Acad Sci USA 107: 5863-5868, 2010.
75. Xu Y, Martin S, James DE, Hong W. GS15 forms a SNARE complex with syntaxin 5, GS28, and Ykt6 and is implicated in traffic in the early cisternae of the Golgi apparatus. Mol Biol Cell 13: 3493-3507, 2002.
76. Yuan JX, Rubin LJ. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation 111: 534-538, 2005.
77. Zhan X, Li D, Johns RA. Immunohistochemical evidence for the NO cGMP signaling pathway in respiratory ciliated epithelia of rat. J His-tochem Cytochem 47: 1369-1374, 1999.
78. Zhao YY, Zhao Y, Mirza MK, Huang JH, Potula HHSK, Vogel SM, Brovkovych V, Yuan JX, Wharton J, Malik AB. Persistent eNOS activation secondary to caveolin-1 deficiency induced pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 119: 2009-2018, 2009.
79. Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J, Bauer PM, Choi JJW, Curtis E, Choi AMK, Gladwin MT. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreduc-tase-dependent nitric oxide generation. Circulation 121: 98-109, 2010.